|
"Molecular Signatures of Lethal and Indolent Prostate Cancer"
|
5R01CA116337-05
|
$524,925
|
$131,231
|
RUBIN, MARK
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
|
15-Lipoxygenase-2 (ALOX15B) as a Tumor Suppressor
|
5R01CA131445-03
|
$221,524
|
$55,381
|
NIE, DAOTAI
|
SOUTHERN ILLINOIS UNIVERSITY SCH OF MED
|
|
18F-FACBC PET-CT for the Detection and Staging of Recurrent Prostate Carcinoma
|
5R01CA129356-04
|
$349,147
|
$87,287
|
Schuster, David
|
EMORY UNIVERSITY
|
|
1H MRI based nanosensors for imaging tumor oxygenation
|
5R21CA132096-02
|
$207,240
|
$51,810
|
Kodibagkar, Vikram
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
3-D Transrectal Ultrasound with 2-D Arrays
|
5R01CA116379-03
|
$246,645
|
$61,661
|
YEN, JESSE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis
|
5R01CA129484-03
|
$393,213
|
$24,576
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
A Culturally Appropriate Cervical Cancer Intervention for Underserved Vietnamese
|
5R01CA111570-05
|
$372,622
|
$372,622
|
MA, GRACE
|
TEMPLE UNIVERSITY
|
|
A Follow-up Study for Causes of Illness in Black Women
|
5R01CA058420-17
|
$1,766,131
|
$883,066
|
Rosenberg, Lynn
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Genome-wide Association Study of Prostate Cancer in African Americans
|
3U01CA136792-02S1
|
$915,027
|
$228,757
|
HENDERSON, BRIAN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
A Genome-wide Association Study of Prostate Cancer in African Americans
|
5U01CA136792-02
|
$2,379,805
|
$594,951
|
HENDERSON, BRIAN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
A Longitudinal Study of the Predictors of Smoking in Women in Late Midlife
|
5R01CA122128-03
|
$594,268
|
$594,268
|
BROOK, JUDITH
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
A mouse model of stem cell deregulation and lung cancer
|
5R01CA076354-10
|
$264,921
|
$52,984
|
LOCKER, JOSEPH
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
A Multi-State Study of Cancer Treatment and Outcomes Among American Indians
|
5R01CA125231-04
|
$286,758
|
$21,507
|
RAMSEY, SCOTT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
A Neoadjuvant Trial of Anastrazole and A Novel SRC Inhibitor, AZD0530, for LABC
|
5R21CA133884-02
|
$297,018
|
$297,018
|
SLINGERLAND, JOYCE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
A novel function of TIMP-1
|
5R01CA089113-08
|
$269,442
|
$26,944
|
KIM, HYEONG-REH
|
WAYNE STATE UNIVERSITY
|
|
A Novel Synthetic Androgen Receptor Antagonist
|
5R01CA131137-03
|
$323,700
|
$80,925
|
DONG, ZHONGYUN
|
UNIVERSITY OF CINCINNATI
|
|
A Phase I/II Trial of Eltrombopag in Elderly Acute Myeloid Leukemia Patients
|
1R21CA153018-01
|
$332,000
|
$332,000
|
Gewirtz, Alan
|
UNIVERSITY OF PENNSYLVANIA
|
|
A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese
|
5R01CA121023-04
|
$533,482
|
$533,482
|
WANG, JUDY
|
GEORGETOWN UNIVERSITY
|
|
A Platform for Cancer Biomarker Validation: Image Fusion Using NIR Fluorescence
|
5R01CA134493-02
|
$661,011
|
$165,253
|
FRANGIONI, JOHN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A Pooled Analysis to Identify New Ovarian Cancer Risk Factors
|
5R01CA136891-02
|
$333,819
|
$333,819
|
PEARCE, CELESTE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
A Population Based Policy Model for Colorectal Cancer
|
3U01CA088204-09S1
|
|
$0
|
KUNTZ, KAREN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
A Rigid Multivalent Chemical Platform for Targeted Diagnostics and Therapeutics
|
5F32CA132332-03
|
$55,790
|
$13,948
|
Nasr, Khaled
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A Serum Marker for Aggressive Prostate Cancer
|
5R01CA121460-05
|
$448,648
|
$112,162
|
PEEHL, DONNA
|
STANFORD UNIVERSITY
|
|
A Sustainable Approach to Increasing Cancer Screening in Community Health Centers
|
5R01CA126596-04
|
$558,128
|
$139,532
|
EMMONS, KAREN
|
DANA-FARBER CANCER INSTITUTE
|
|
A Systems Genetics Analysis of Cancer Risk, Progression and Therapeutic Response
|
5U01CA084244-12
|
$826,688
|
$165,338
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
A Tool for Geospatial Analysis of Physical Activity
|
3U01CA130771-04S1
|
$154,312
|
$154,312
|
Patrick, Kevin
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
A Tool for Geospatial Analysis of Physical Activity
|
3U01CA130771-04S2
|
$1,000
|
$1,000
|
Patrick, Kevin
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
A Tool for Geospatial Analysis of Physical Activity
|
5U01CA130771-04
|
$622,328
|
$622,328
|
Patrick, Kevin
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
A2a receptor engagement promotes T cell tolerance
|
5R01CA114227-05
|
$254,392
|
$63,598
|
POWELL, JONATHAN
|
JOHNS HOPKINS UNIVERSITY
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196 03152
|
$1,684,362
|
$842,181
|
Schatzkin, Arthur
|
DCEG (NCI)
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S6
|
$7,064,076
|
$141,282
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S7
|
$100,000
|
$2,000
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S8
|
$50,000
|
$1,000
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Academic Training in Medical Oncology
|
5T32CA009297-27
|
$304,451
|
$15,223
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Adiposity and Outcomes of Clinically Localized Prostate Cancer
|
5R01CA129140-02
|
$628,470
|
$157,118
|
Freeman, Vincent
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY
|
5R01CA116195-06
|
$251,751
|
$62,938
|
BOSLAND, MAARTEN
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Adverse Drug Reactions in Geriatric Cancer Patients
|
5K01CA134554-03
|
$126,535
|
$126,535
|
MCKOY, JUNE
|
NORTHWESTERN UNIVERSITY
|
|
Agents for Specific NMR and SQUID Imaging of Prostate Cancer
|
5R01CA123194-04
|
$463,665
|
$115,916
|
Sillerud, Laurel
|
UNIVERSITY OF NEW MEXICO
|
|
Aging and Primary Central Nervous System Tumors
|
ZIA BC 011348
|
$95,980
|
$71,985
|
Iwamoto, Fabio
|
CCR (NCI)
|
|
Aldo-Keto Reductases and PAH Metabolism/Activation
|
5R01CA039504-24
|
$289,179
|
$14,459
|
Penning, Trevor
|
UNIVERSITY OF PENNSYLVANIA
|
|
Alternative splicing and epithelial-mesenchymal plasticity in prostate tumors
|
5R01CA127727-02
|
$323,700
|
$80,925
|
Garcia-Blanco, Mariano
|
DUKE UNIVERSITY
|
|
American College of Radiology Imaging Network
|
5U01CA080098-12
|
$9,041,302
|
$452,065
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
An androgen receptor coactivator regulated in prostate
|
5R01CA112226-03
|
$351,713
|
$87,928
|
LOGAN, SUSAN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
An Exercise Intervention to Improve Health in Postmenopausal Cancer Survivors
|
5R01CA122658-04
|
$585,231
|
$585,231
|
KNOBF, M. Tish
|
YALE UNIVERSITY
|
|
Analysis of Lag-3 in Regulatory T Cell Function and Immune Supression
|
5R01CA127153-03
|
$340,300
|
$85,075
|
DRAKE, CHARLES
|
JOHNS HOPKINS UNIVERSITY
|
|
Analysis of recombination in vivo
|
1R21CA144022-01A1
|
$226,907
|
$226,907
|
SCULLY, RALPH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Analysis of the STAT3 Pathway In Tumor Tolerance and Immune Evasion
|
5R01CA125192-05
|
$282,659
|
$70,665
|
PARDOLL, DREW
|
JOHNS HOPKINS UNIVERSITY
|
|
Androgen and Soluble Guanylyl Cyclase Signaling in Prostate Cancer
|
5R01CA127873-03
|
$270,081
|
$67,520
|
SHEMSHEDINI, LIRIM
|
UNIVERSITY OF TOLEDO
|
|
Androgen Receptor Function in Prostate Cancer
|
5R01CA086072-08
|
$320,588
|
$80,147
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Androgenic Inactivation of FOXO1 in Prostate Cancer
|
5R01CA125747-08
|
$263,376
|
$65,844
|
TINDALL, DONALD
|
MAYO CLINIC
|
Total relevant funding to Aging for this search: $123,095,361
|